Viewing Study NCT00101257


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-24 @ 8:40 PM
Study NCT ID: NCT00101257
Status: COMPLETED
Last Update Posted: 2010-05-07
First Post: 2005-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent ovarian epithelial cancer View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None peritoneal cavity cancer View